Meta-Analysis
Copyright ©The Author(s) 2023.
World J Gastrointest Surg. Oct 27, 2023; 15(10): 2320-2330
Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2320
Table 1 Characteristics of included studies
Ref.
Design
Sample size, n
Age in year
Sex, male/female
Start of time calculation
Primary end-point(s)
Follow-up time
Elramah et al[24]RC52361-Admission timeMortality rate; Cure rate9 year
Giraudo et al[23]RC74628.8343/380Admission timeComplications rate; Mortality rate6 year
Lee et al[25]RC107635.2 ± 17.1612/464Time of symptom onsetCure rate; Complications rate3 year
Maroju et al[28]PC11428.386/28Time of symptom onsetLength of hospital stay1 year
Kim et al[29]RC19233.6 ± 19.599/93Time of symptom onsetComplications rate; Length of hospital stay1 year
Saar et al[30]PC27035.4 ± 14.8136/130Time of symptom onsetCure rate1 year
Rause et al[22]RC1976851%/49%Admission timeMortality rate8 year
Azuhata et al[26]PC15466.5 ± 13.988/66Admission timeSurvival rate4 year
Wen and Tang[27]RC10156.26 ± 15.765/36Admission timeMortality rate; Length of hospital stay3.5 year
Table 2 Results of quality assessment using the Newcastle-Ottawa Scale for case-control studies
Ref.Selection
Comparability
Exposure
Quality score
Adequate definition of cases
Representativeness of the cases
Selection of controls
Definition of controls
Comparability of cases and controls on the basis of the design or analysis
Ascertainment of exposure
Same method of ascertainment for cases and controls
Non-Response rate
Elramah et al[24]11-111117
Giraudo et al[23]11-111117
Lee et al[25]11-111117
Maroju et al[28]11-111117
Kim et al[29]11-111117
Saar et al[30]11--21117
Rause et al[22]11--11116
Azuhata et al[26]11-121118
Wen and Tang[27]11-121118